| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |